# A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy

> **NCT02803151** · NA · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 59 (estimated)

## Conditions studied

- Metastasis of Malignant Neoplasm to Lymph Node

## Interventions

- **RADIATION:** Stereotactic ablative radiotherapy

## Key facts

- **NCT ID:** NCT02803151
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2020-05
- **Final completion:** 2021-05
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2019-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02803151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02803151, "A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02803151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*